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Aims The contribution of blood flow to angiogenesis is incompletely understood. We examined the effect of blood flow on
Notch signalling in the vasculature of zebrafish embryos, and whether blood flow regulates angiogenesis in zebrafish
with constitutively up-regulated hypoxic signalling.
Methods
and results
Developing zebrafish (Danio rerio) embryos survive via diffusion in the absence of circulation induced by knockdown of
cardiac troponin T2 or chemical cardiac cessation. The absence of blood flow increased vascular Notch signalling in 48 h
post-fertilization old embryos via up-regulation of the Notch ligand dll4. Despite this, patterning of the intersegmental
vessels is not affected by absent blood flow.We therefore examined homozygous vhlmutant zebrafish that have consti-
tutively up-regulated hypoxic signalling. These display excessive and aberrant angiogenesis from 72 h post-fertilization,
with significantly increased endothelial number, vessel diameter, and length. The absence of blood flow abolished
these effects, though normal vessel patterning was preserved.
Conclusion We show that blood flow suppresses vascular Notch signalling via down-regulation of dll4. We have also shown that
blood flow is required for angiogenesis in response to hypoxic signalling but is not required for normal vessel patterning.
These data indicate important differences in hypoxia-driven vs. developmental angiogenesis.
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1. Introduction
Angiogenesis is essential for normal embryonic development, yet is central
to postnatal human diseases such as retinopathies and cancer. During em-
bryonic development, early vascular formation must precede onset of
cardiac contraction, and hence vasculogenesis (formation of the axial
vessels by migration of mesodermal angioblasts) occurs prior to, and
independent of, blood flow. However, the contribution of blood flow to
subsequent patterning of the vasculature by angiogenesis is less clear.
The zebrafish is an outstanding model of vertebrate angiogenesis
due to optical clarity and a range of transgenic lines allowing in vivo
visualization of cellular behaviour. Strikingly, the embryo is not depend-
ent uponacirculation foroxygenation, as it obtains sufficient viadiffusion
from the incubating medium until several days old.1 Thus, the zebrafish
embryoheart canbe stoppedwithout inducinghypoxia, allowing thedis-
crimination of the effects of blood flow without the confounding influ-
ence of ischaemia.2 This makes it well suited to examining the effect of
blood flow on vascular development.
We previously showed that during zebrafish development, formation
of the paired intersegmental vessels (ISVs) running between the somites
from the aorta occurs in the absence of blood flow.3 This suggests that
initiation of ISV formation is blood flow independent, although a recent
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study suggests bloodflowcontributes to the anastomosisof ISVs to form
the dorsal longitudinal anastomotic vessel (DLAV).4 In contrast with ISV
formation, development of other vessels in the zebrafish does require
blood flow, such as the accessory fifth aortic arch (AA5x).5 We previ-
ously showed blood flow negatively regulates endothelial expression
of the chemokine receptorCXCR4a.3CXCR4a is required forhindbrain
vascularization (but not ISV formation)6 by stabilizing angiogenesis.7 It is
unknownwhy development of the AA5x and hindbrain vasculature, but
not ISVs, requires blood flow.
In contrastwith these studies that have shownbloodflow is either dis-
pensable or necessary for vessel formation, other reports have shown a
more inhibitory effect of blood flow on vascular formation. Shear stress
has been shown to inhibit sprouting angiogenesis either in vitro8 or in
vivo.9 Clearly, much remains to be understood how the physical forces
exertedbybloodflowintegratewithmolecularmechanismsto influence
angiogenesis.
Notch signalling refers to a rangeof cell–cell interactionswhereNotch
ligands, such as the delta-like ligands (dll1-4) and jaggeds ( jag1&2) interact
with Notch receptors on neighbouring cells to induce alterations in gene
expression and cellular phenotype.10 These effects are predominantly
mediated via the transcription factor CSL. Notch signalling plays a
central role in vascular development and angiogenesis.10 Although
Notch signalling is required for vasculogenesis and axial vessel forma-
tion,11 during later developmental angiogenesis Notch signalling plays an
inhibitory role. For example, during ISV formation, endothelial tip cells
express the Notch ligand dll4, which induces Notch signalling in adjacent
endothelial stalk cells. Loss of function of dll4 leads to excessive and aber-
rant angiogenesis12 including of the ISVs in zebrafish.13
To identify mechanisms whereby blood flowmight regulate angiogen-
esis, we examined whether blood flow influences Notch signalling in the
developing zebrafish vasculature. We find that in the absence of blood
flow the Notch ligand dll4 is up-regulated in the zebrafish vasculature,
leading to increased Notch signalling. However, as previously demon-
strated, the absence of blood flow does not affect ISV patterning in wild-
type embryos, suggesting the up-regulation of Notch signalling is insuffi-
cient toperturbnormaldevelopmental angiogenesisof the ISV.Wethere-
fore examined ISV formation in zebrafishwith constitutively up-regulated
hypoxic signalling due to homozygousmutation in the vonHippel Lindau
proteingene vhl.14Wefind theseembryosdisplayabnormalandexcessive
ISVangiogenesis that is completelyabolished in the absenceofbloodflow,
whereas normal ISV patterning is preserved. Thus, our data reinforce the
suggestion that the contribution of blood flow to angiogenesis is highly
context dependent, and that blood flow is required in the clinically im-
portant context of angiogenesis driven by hypoxic signalling.
2. Methods
2.1 Fish strains
Studies were performed underHomeOffice licence 40/3434 and conformed
to Directive 2010/63/EU of the European Parliament. The vhlhu2117 mutant
was previously described.14 This was crossed with the following transgenic
lines: Tg(fli:eGFP),15 kindly supplied by Brant Weinstein, Tg(flk1:EGFP-nls)16
kindly supplied by Markus Affolter, and Tg(kdrl:HRAS-mCherry)s916 17 kindly
supplied byArndt Siekmann. The Tg(CSL-venus)qmc61transgenic linewas gen-
erated by co-author Gering’s group.
2.2 Morpholino knockdown
Morpholino antisense oligonucleotide (Gene Tools, Oregon USA) were
diluted in phenol red (Sigma UK) 0.5% solution and injected into the yolk
of a 1–4 cell embryo at a dose of 4.2 ng. Morpholino sequences were:
tnnt2 (ATG/start) blocking morpholino 5′CATGTTTGCTCTGACTTGA
CACGCA3′ as published,18Controlmorpholino5′CCTCTTACCTCAGTT
ACAATTTATA 3′ (Gene Tools stock control), and dll4 (ATG/start)
blocking morpholino: 5′-GAGAAAGGTGAGCCAAGCTGCCATG-3′ as
published.19
2.3 Drug treatments
The myosin ATPase inhibitor 2,3-butanedione 2-monoxime (BDM) (Sigma
UK)was used to block cardiac contraction in the developing embryo as pre-
viously published.20 This was dissolved at [15 mM] in E3 embryo media and
added after established embryonic circulation at 36 h post-fertilization (hpf)
until imaging at 3 dpf.
2.4 Reverse transcription–quantitative
polymerase chain reaction
RNAwas extracted from the dissected trunk and tail segments of groups of
30 pooled 48 hpf embryos. RNA was isolated immediately using Trizol
(Sigma, UK) and then chloroform extracted and subsequently precipitated.
cDNA was synthesized from the purified RNA using the Verso cDNA
reverse transcription kit (Thermo Scientific, UK). Reverse transcription–
quantitative polymerase chain reaction (RT–qPCR) was performed using
iQ SYBR green supermix with a My iQ cycler (BioRad USA). Primers:
b-actin forward (5′-GCAGAAGGAGATCACATCCCTGGC-3′), B-actin
reverse (5′-CATTGCCGTCACCTTCACCGTTC-3′), cxcr4a forward
(5′-TTGTGCTCACTCTGCCATTC-3′), cxcr4a reverse (5′-ACCGGTCC
AAACTGATGAAG-3′), dll4 forward (5′- GCTTGGCTCACCTTTCT
CAT-3′), dll4 reverse (5′-CGGAAGAAAGTCCTGCAGTC-3′), Nrarpa
forward (5′-AGCTGCTTCGGACTCGTTAC-3′), Nrarpa reverse
(5′-CGAGGTAGCTGATGCAGAGA-3′), Notch 3 forward (5′- CGGC
CTGGTTATATTGGTTC-3′), Notch 3 reverse (5′-TCTAAAGCCTCGC
TGACACA-3′), her12 forward (5′-GCTGAGGAAGCCGATAGTTG-3′),
her12 reverse (5′-GCGAGAGGAAGTGGACAGAC-3′), ephrin B2
forward (5′-ACCACGTTGTCACTCAGCAC-3′) ephrin B2 reverse
(5′-AGATGTTTGCTGGGCTCTGT-3′), flt4 forward (5′-TCTCGTTAGT
GCCGTATCCA-3′), flt4 reverse (5′-GATGATGTGTGCTGGCTGTT-3′),
kdr/flt1 forward (5′-CGCGCAACAGGTCACTATT-3′), kdr/flt1 reverse
(5′-GTGAGGAGGATGTCGAGGAG-3′), vegfcc forward (5′- AAGAAG
CTGGATGAGGAGACG-3′), vegfcc reverse (5′-GAGGTTGACTCC
TCGGACAC-3′), vegfab forward (5′-CAGTGTGAGCCTTGCTGTTC-3′),
and vegfab reverse (5′- CCATAGGCCTCCTGTCATTT-3′).
2.5 RT–qPCR for miR-30b and miR-30c
qPCRof zebrafishmaturemicroRNA (miR)was performed according to the
manufacturer’s instructions using TaqMan MicroRNA Assays. Briefly, total
RNA from groups of 30 pooled 48 hpf zebrafish embryos was purified
using Trizol. cDNA was prepared using the TaqMan microRNA Reverse
Transcription kit (Applied Biosystems) and qPCR performed using
TaqMan microRNAAssays for miR-30b and miR-30c (Applied Biosystems).
The primers used for RT–qPCR were supplied with each assay. Each is a
stem-loop oligonucleotide containing the sequence of the mature miR
(miR-30b:UGUAAACAUCCUACACUCAGCU; miR-30c: UGUAAACA
UCCUACACUCUCAG).
qPCR was performed in triplicate using a 7900HT Fast Real-Time PCR
System (Applied Biosystems). miR-30b and miR-30c expression levels
were normalized to mean expression of the control group at 48 hpf.
2.6 Whole mount RNA in situ hybridization
Experiments were performed as previously described.3 Expression was
detected with RNA probes labelled with digoxigenin (Roche) and resolved
using BM Purple (Roche). dll4 antisense probe was synthesized from delta-
like 4 cDNA fragment (kind gift from Roger Patient, Oxford, UK).
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2.7 Live imaging and microscopy
Embryoswere lightly anaesthetized usingMS-222 (Tricaine) added to the in-
cubating medium and immobilized in 0.5% low-melting point agarose and
mounted in a chamber slide for visualization. Confocal microscopywas per-
formedusing an IX81 invertedmotorizedmicroscope (Olympus), Ultraview
VOX confocal spinning disc imaging system (Perkin Elmer, Waltham, MA,
USA). Images were acquired using Velocity software v5.3.2 (Perkin Elmer).
Z stack images were acquired in 2 mm slices using sequential laser scanning
of the region of interest. All analyses and quantification of vessel parameters
were performed using ImageJ (v1.44 public domain software http://rsbweb.
nih.gov/ij/). Stacks are presented as the maximum intensity Z projections.
To quantify aortic Notch signalling in CSL:venus transgenics, we quantified
fluorescence intensity in a two somite length of the wall of the aorta just
above the anus. Toquantify the vessel length in Fli1:GFPor kdrl:HRAS-mCherry
transgenics we quantified the entire length of endothelium present in a
region spanning two somites (containing three ISVs, and the dorsal longitu-
dinal anastamotic vessel and any aberrant ISV sprouts). To quantify endothe-
lial cell nuclei in flk1:GFPnls transgenics we counted the total nuclei in two
somites, including the aorta, ISVs, and dorsal longitudinal anastamotic
vessel. Stacks were analysed blinded and group sizes are as specified.
2.8 Statistics
Statistical comparisons were by Student’s t-test for two group comparisons
orANOVA formore than two groups, andwere performed usingGraphpad
Prism software. Group sizes are indicated in the results section. A P, 0.05
was considered statistically significant. Quantitative data are presented as
mean+ SEM.
3. Results
3.1 Absence of blood flow leads to
up-regulation of endothelial notch signalling
Morpholino antisense knockdown of cardiac-specific troponin T2
(tnnt2) has been shown to prevent cardiac contraction during develop-
ment,18 although embryos survive for several days with otherwise
normal development.3
To examine whether blood flow alters Notch signalling, we induced
morpholino antisense knockdown of tnnt2 in a transgenic zebrafish
line Tg(CSL:venus)qmc61. This expresses the YFP derivative Venus
driven by concatemerized CSL-binding sites (the DNA-binding site of
the CSL transcription factor required for most Notch signalling). In
these embryos, Venus is expressed at sites of Notch signalling, notably
the neural tube and less strongly in the developing vasculature, and is a
useful reporter for Notch signalling. tnnt2 knockdown prevented
cardiac contraction in these embryos at all time points studied up to
5 dpost-fertilization (dpf); noerythrocytemovement couldbedetected
in any blood vessel in tnnt2 morphants, whereas in control morphants
brisk blood flow was observed in all vessels.
When we examined venus expression in the vasculature in these
transgenic embryos at 72 h post-fertilization (hpf) we observed a statis-
tically significant up-regulation of Notch signalling in the aorta of tnnt2
morphants. Figure 1A shows the vascular anatomy of a zebrafish
embryo for orientation; the area of trunk examined in subsequent
studies is indicated by a box. Figure 1B shows the trunk region of a rep-
resentative control and tnnt2morphant Tg(CSL:venus)qmc61 transgenic.
Reporter expression can be seen in the aorta (arrowhead) and neural
tube running dorsally to the aorta in both embryos, but the intensity
of aortic expression is greater in the tnnt2 morphant. We quantified
the reporter expression in the aorta in 72 hpf control and tnnt2 mor-
phants (nine per group) and found a statistically significant increase in
aortic fluorescence induced by tnnt2 knockdown (P, 0.001), shown
in Figure 1D. We repeated this experiment in 48 hpf embryos and
found a similar up-regulation of reporter expression (Supplementary
material online, Figure S1). These observations suggested that blood
flow may suppress CSL-mediated Notch signalling in the vasculature
at these developmental stages.
tnnt2 knockdown prevents circulation from ever commencing and
could have effects other than preventing blood flow. We therefore
sought to reproduce these findings using another method and
examine whether absent blood flow increases Notch signalling in
embryos that have previously experienced blood flow. Incubation of
zebrafish embryos in the myosin ATPase inhibitor 2,3-butanedione 2-
monoxime (BDM) has been shown to induce reversible cessation of
cardiac contraction.20We therefore used BDM to stop cardiac contrac-
tion in Tg(CSL:venus)qmc61 zebrafish embryos from 36 hpf (onset of cir-
culation was at 26 hpf) until 72 hpf. Although a brisk normal circulation
was established in all embryos at 36hpf, BDM treatment halted cardiac
contraction within 15 min, causing complete absence of circulation. As
with tnnt2 knockdown, cessation of cardiac output by BDM led to a sig-
nificantup-regulationofVenus expression in the aorta (Figure1C).When
we quantified this effect, we found that cessation of blood flow led to a
statistically significant increase in aortic Notch signalling (n ¼ 8/group,
P, 0.01) shown in Figure 1E). Taken together, these experiments
suggest that the absence of blood flow leads to up-regulation of
Notch signalling in the vasculature by some mechanism.
3.2 Absence of blood flow leads to
up-regulation of endothelialNotch signalling
by up-regulation of dll4
To determine how blood flow might regulate Notch signalling, we
extracted RNA from the trunk of 48 hpf tnnt2 and control morphants
(3 replicateexperimentsof 30embryosper group) andperformedquan-
titative rt–PCR for a rangeofNotch ligands and receptors, VEGF ligands
and receptors, and CXCR4a (Figure 2A). As we previously described,
CXCR4a was significantly up-regulated by the absence of blood flow
(P, 0.05).3 The Notch ligand dll4 was also significantly up-regulated
in tnnt2morphants (P, 0.05).
To examine spatial localization of the dll4 expression, we performed
wholemount in situ hybridization in 48 hpf control and tnnt2morphants.
This confirmed dll4was up-regulated within the aorta and ISVs of tnnt2
morphants. Representativemicrographs are shown in Figure 2B; 10 of 10
control morphants had the appearance shown, whereas 12 of 13 tnnt2
morphants had clear up-regulation of dll4 as depicted. It should be
noted that our in situ protocol was optimised to show dll4 upregulation
in the absence of flow; more prolonged staining revealed aortic and ISV
expression of dll4 in embryos with blood flow, but this was substantially
less than in embryos without flow).
The above data suggested that the up-regulation of Notch signalling
induced by the absence of blood flow in Figure 1 could be mediated
via dll4 up-regulation. To test this, we co-injected a previously published
dll4 morpholino with or without the tnnt2 morpholino to knockdown
dll4 in 3 dpf Tg(CSL:venus)qmc61 embryos with or without blood flow.
In the presence of flow dll4 knockdown did not alter Venus expression
in the aorta (n ¼ 19) compared with control morphants (n ¼ 18). This
lack of effect of dll4 knockdownon reporter expression in embryoswith
blood flow may be due to insensitivity of the reporter, perdurance or
consitutive CSL activity. However, as before, tnnt2 knockdown
induced a significant increase in Notch signalling (n ¼ 11, P, 0.001).
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However, in similar tnnt2 morphants, dll4 knockdown was sufficient to
prevent the up-regulation of aortic Notch signalling detected by
Venus expression induced by tnnt2 knockdown (n ¼ 11). Figure 3A
shows representative micrographs of the trunk vasculature in control
and tnnt2 morphants with and without dll4 knockdown. Figure 3B
shows the quantification of the aortic fluorescence from all the
embryos examined. These data confirmed that the absence of blood
flow leads to up-regulation of Notch signalling via up-regulation of dll4
expression.
Our finding that dll4was up-regulated in 48 hpf tnnt2morphants was
surprising, as previous studies reporteddown-regulationofdll4 in 36 hpf
tnnt2 morphants (but not 24 hpf) by in situ hybridization and qPCR.21
Wethereforeextendedourexperiments to72 hpf embryos,whichcon-
tinued to show up-regulation of dll4 in the vessels of tnnt2 morphants
(Supplementary material online, Figure S2). This is consistent with the
up-regulation of Notch signalling seen at the same developmental
stage (Figure 1). It appears therefore that although Wang et al. showed
down-regulation of dll4 in tnnt2morphants at earlier stages of develop-
ment, this is subsequently followed by up-regulation for at least the fol-
lowing 36 h.
Recent work has shown that the microRNA species miR-30b and
miR-30c regulate dll4.22 We therefore questioned whether the effect
of blood flow on dll4 levels is mediated via effects on the expression
of this microRNA. We performed qPCR to quantify the expression of
both miR-30b and miR-30c in 48 hpf control and tnnt2 morphant
embryos. We found no significant difference in the expression of
either miR (Supplementary material online, Figure S3), suggesting
blood flow does not suppress dll4 expression via miR-30.
3.3 Absence of blood flow does not affect
normal ISV patterning but prevents
excessive angiogenesis in vhl mutants with
constitutively activated hypoxic signalling
dll4 is expressed by endothelial tip cells during ISV formation, and reduc-
tion of dll4 expression leads to excessive and aberrant ISV angiogen-
esis.23 However, despite the absence of blood flow leading to
up-regulation of dll4 expression and Notch signalling, we previously
showed this is not associated with abnormal ISV formation in wild-type
embryos,3 which do not experience hypoxia in the absence of blood
flow.1 We therefore asked whether blood flow would be required for
angiogenesis driven by up-regulation of hypoxic signalling. Low tissue
oxygen levels lead to increasedHIF1a signalling, which induces gene ex-
pression changes that are highly pro-angiogenic.24 However, incubation
Figure 1 The absence of blood flow increases endothelial Notch signalling. (A) Vascular anatomy of a Fli1:eGFP transgenic zebrafish (vascular reporter
line) fororientation. Scale bar ¼ 500 mm.Aboxed regionof trunk indicates site of (B) and (C). (B) 3 dpf Tg(CSL-venus)qmc61 transgenic embryoswith blood
flow (control MO) or no blood flow (tnnt2 MO). Scale bar ¼ 100 mm. Arrowhead indicates dorsal aorta. (C) The mean aortic fluorescence in 3 dpf
Tg(CSL-venus)qmc61 embryos control and tnnt2 morphants. Scale bar ¼ 100 mm. (D) 3 dpf Tg(CSL-venus)qmc61 transgenic embryos with blood flow
(vehicle treated) or no blood flow (15 mM BDM treatment) from 36 hpf. ISVs, intersegmental vessels. Scale bar ¼ 100 mm. (E) The mean aortic fluores-
cence in 3 dpf Tg(CSL-venus)qmc61 embryos in vehicle- and BDM-treated groups.
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of zebrafish embryos in hypoxia leads to a reduction in cardiac output
and blood flow, preventing direct testing of the interactions between
low oxygen tension and blood flow during angiogenesis.
We therefore examined vascular development in zebrafish embryos
that have constitutively activatedHIF1a signalling due tomutation in the
von Hippel Lindau (vhl) gene.14 These embryos have previously been
shown to exhibit excessive angiogenesis due to up-regulation of VEGF
signalling.25 These mutants therefore represent a powerful model of
hypoxic-signalling driven angiogenesis. We crossed vhl mutants with
existing transgenic lines that allowed visualization of endothelial cells,
cytoplasm (Fli1:GFP15), nuclei (Flk1:GFPnls16), or endothelial membrane
(kdrl:HRAS-mCherry17).
Figure 4B–D showhigher power images of the ISVs in a representative
wild-type embryo at 3, 4, and 5 dpf. By 3 dpf, the ISV pattern is largely
established, with limited remodelling over the subsequent 2 days.
Figure 4E–G show the same region in a vhl2/2 mutant. As previously
described,25 vhl2/2 mutants exhibited aberrant ISV angiogenesis that
became more apparent between 3 and 5 days post-fertilization (dpf).
We quantified ISV diameter and compared with wild types (n ¼ 5)
this was significantly increased in vhl2/2 mutants [n ¼ 5, P, 0.001),
Figure 4H]. Similarly, whenwequantified ISV length, this was significantly
greater in vhl2/2 mutants (n ¼ 5, P, 0.001) compared with wild types
(n ¼ 5).
We next examined the effect of preventing cardiac contraction by
tnnt2 knockdown on abnormal ISV formation in vhl2/2 mutants. Repre-
sentative3 dpf Fli1:GFPwild-typeand vhl2/2mutant transgenicswith and
without tnnt2 knockdown are shown in Figure 5A. Although as we previ-
ously described, tnnt2 knockdown did not affect ISV patterning in wild-
type embryos (aside from a collapsed appearance due to lack of blood
flow), the excessive ISV angiogenesis in homozygous vhl2/2 mutants
was completely abolished. When we quantified ISV length, we con-
firmed that tnnt2 knockdown did not significantly affect this in wild-type
embryos (n ¼ 5/group), but that tnnt2 knockdown reduced the
increased total vessel length in vhl2/2 mutants to wild-type levels
(P, 0.001, n ¼ 5–7/group) (Figure 5B).
The Flk1:GFPnls transgenic labels endothelial nuclei, allowing quantifi-
cation of endothelial cell number.We therefore examined the effect of
prevention of blood flow by tnnt2 knockdown on endothelial cell
number in 3 dpf wild-type and vhl2/2 mutant embryos. Representative
3 dpf Flk1:GFPnls wild-type and vhl2/2 mutant transgenics with and
without tnnt2 knockdown are shown in Figure 5C. When we quantified
endothelial cell number, we found that compared with wild-type
embryos with normal blood flow (n ¼ 20), tnnt2 knockdown (n ¼ 8)
did not significantly affect endothelial cell number in a two-somite
region of the mid trunk. As might be expected from the excessive
vessel formation seen in Fli1:GFP vhl2/2 mutants shown in Figure 4E–G,
Figure 2 The absence of blood flow up-regulates the expression of dll4 (A) Quantitative RT–PCR for Notch ligands and receptors, VEGF ligands and
receptors, and cxcr4a performed on trunk RNA from 48 hpf control and tnnt2morphants. (B)Whole mount in situ hybridization for dll4 in 48 hpf control
and tnnt2morphants. Arrowhead indicates dorsal aorta, ISVs in tnnt2morphant arrowed. Scale bar ¼ 100 mm.
Figure 3 dll4 knockdown blocks the up-regulation of Notch signal-
ling in the absence of blood flow (A) The effect of dll4 knockdown on
reporter expression in 3 dpf Tg(CSL-venus)qmc61 embryos with and
without blood flow due to tnnt2 knockdown. Arrowhead indicates
dorsal aorta and arrow indicates an ISV. (B) The mean aortic fluores-
cence in 3 dpf control and dll4 morphant Tg(CSL-venus)qmc61
embryos with and without blood flow due to tnnt2 knockdown.
Scale bar ¼ 100 mm.
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in the presence of blood flow vhl2/2 mutants (n ¼ 11), had a significantly
greater number of endothelial cells (P, 0.001) compared with wild-
types (Figure 5D). However, prevention of blood flow in vhl2/2
mutants by tnnt2 knockdown (n ¼ 11) reduced this to wild-type levels
(P, 0.001), confirming that blood flow is required for the excessive
angiogenesis in vhl2/2 mutants.
To confirm that the effect of tnnt2 knockdown on angiogenesis in
vhl2/2mutants could be seen by preventing blood flowusing an alterna-
tivemethod,we exposedwild-type and vhl2/2mutant embryos to BDM
from 36 hpf until 72 hpf. We performed these experiments using a
double transgenic ( flk1:EGFP-nls labelling endothelial nuclei with GFP
and kdrl:HRAS-mCherry labelling endothelial membrane with mCherry),
allowing simultaneous quantification of vessel length and endothelial
cell number. Figure 6A shows representative 3 dpf wild-type and
vhl2/2 double transgenics with andwithout BDM treatment. In control-
treated vhl2/2 mutants with blood flow, excessive endothelial cell
number and ISV sprouting is apparent, whereas BDM treatment signifi-
cantly reduced both vessel length (Figure 6B, P, 0.001) and endothelial
cell number (Figure 6C, P, 0.001) to wild-type levels (n ¼ 11/group).
The data confirmed that the absence of blood flow prevented the
excess ISV angiogenesis in vhl2/2 mutants, though preserving normal
ISV architecture and endothelial cell number.
4. Discussion
Most studies of angiogenesis use in vitromodels that seldom reproduce
the exposure to blood flow. The contribution of blood flow to vascular
development has been little studied, perhaps because angiogenesis
clearly can proceed in the absence of blood flow in vitro and in several
in vivo contexts, such as those that precede cardiac output.
However, recent studies have revealed that the contribution of blood
flow to angiogenesis is highly complex and context-dependent.
Figure 4 vhl2/2 mutant zebrafish demonstrates excessive angiogenesis of trunk vessels during embryonic development. (A) Vascular anatomy of a
Fli:eGFP wild-type embryo for orientation. Scale bar ¼ 500 mm, regions of (B–G) boxed. (B–D) Mid-trunk intersegmental (ISV) and DLAV vessels from
3 to 5 dpf in a wild-type Fli:eGFP transgenic. (E–G) Mid-trunk vessels in a vhl2/2 3–5 dpf Fli:eGFP transgenic. Scale bars for B–G ¼ 25 mm. H; ISV diameter
of 3 dpf wt and vhl2/2 at 3 dpf. I: total ISV length in 3 dpf wt and vhl2/2 mutants.
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Dependent upon the model and vessel studied, published reports have
shown blood flow to be required,5,7 dispensable,3 or inhibitory8,9 for
vessel formation. This uncertainty led us to investigate potential
mechanisms for integration of blood flow with angiogenic pathways.
The zebrafish is an attractive model for this purpose due to its proven
ability tooxygenate via diffusionevenwhencardiac contraction is entire-
ly halted,1 at least in the first several days of development.
TheNotch pathway is a complex and fundamental mechanism in em-
bryonic development and disease. AlthoughNotch signalling is required
for vascular development,11 including lymphatic development,19 it can
also play an inhibitory role in angiogenesis, by repressing tip cell forma-
tion.13,26 The regulation of thismultifaceted contribution to vascular de-
velopment is likely to bemulti-layered.However, we find that theNotch
ligand dll4 is clearly transcriptionally repressedbybloodflow in the aorta
and ISVs of 48 h post-fertilization zebrafish embryos. This provides a po-
tential pathway for blood flow to integrate with other signals to modu-
late angiogenesis. Although Notch ligand/receptor interactions lead to
signalling in both ligand and receptor bearing cells, this does not
appear to affect angiogenesis in the ligand-bearing cell.27 This suggests
that anymodulationof angiogenesis inducedby flowmediated alteration
in dll4 expression is likely to be mediated by effects onNotch receptor-
expressing cells, rather than in an autocrine fashion.
The previous work byWang et al.21 found that the absence of blood
flow led to a decrease in dll4 expression at 36 hpf. Our finding that at
later time points the same manipulation leads to increased dll4
expression is supported by a number of lines of evidence. Wang et al.
did not examine whether tnnt2 knockdown led to alteration in Notch
signalling, whereas we found this is indeed up-regulated by the
absence of blood flow. We also confirmed that a second method of
halting circulation (incubation in the drug BDM) induced up-regulation
of Notch signalling at the same time points used for tnnt2 knockdown
studies. Our findings do not contradict Wang et al., since they studied
earlier stages of development. It is possible that tnnt2 knockdown
does reduce dll4 expression at 38 hpf, but this is followed by the
up-regulation we demonstrate at later time points. The reason for
such a biphasic response is unclear, but the data fromourNotch report-
er studies up to 72 hpf strongly suggest that the overall effect of absent
blood flow is an increase, not a decrease, in vascular Notch signalling.
The exactmechanismwhereby thephysical forces of bloodflow influ-
ence the expression of dll4 remains unclear. Although several transcrip-
tion factors (notably klf2) have been demonstrated to mediate the
transcription of hundreds of genes in response to shear stress, recent
work has highlighted the potential for microRNAs to similarly influence
gene expression in response to haemodynamic alteration.5 Nicoli et al.
showed that blood flow induces klf2a which in turn up-regulates
miR-126. However, recent work suggests miR-126 increases, rather
than decreases dll4 expression,28 suggestingmiR-126 is not themechan-
ism whereby blood flow suppresses dll4.
We examined one candidate, miR-30 which regulates dll4 expression
in other circumstances,22 but found no evidence to suggest this
Figure 5 tnnt2 knockdown prevents excessive angiogenesis in vhl2/2 zebrafish. (A) The mid-trunk vascular anatomy of 3 dpf Tg(fli:eGFP) wild type and
vhl2/2 with andwithout blood flowdue to tnnt2 knockdown (site of imaging boxed in Figure 4A). (B) The total vessel length of 3 dpf wt controlmorphants,
vhl2/2 control morphants, and wt and vhl2/2 tnnt2 morphants. (C) Endothelial nuclei in 3 dpf flk1:EGFP-nls wt and vhl2/2 injected with tnnt2 or control
morpholino. (D) The effect of tnnt2 knockdown on number of endothelial nuclei in a two-somite region of the mid trunk in 3 dpf wild type and vhl2/2.
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particular miR is the link between blood flow and dll4. Although target
prediction algorithms suggest miR-30 is the microRNA species most
likely to target dll4, this does not exclude the possibility that other
miRs regulate dll4 under conditions of altered haemodynamic forces.
The up-regulation of hypoxic signalling in vhl mutants would be pre-
dicted to up-regulate so-called hypoxamirs29 such as miR-210,30
which are highly likely to underlie the angiogenic phenotype and these
may also integrate blood flow with angiogenic signalling. Such a link
would be interesting to explore in future work.
Despite our finding that blood flow regulates Notch signalling, this is
insufficient in itself to alter ISV formation during normal angiogenic de-
velopment, since ISVs form normally, with normal endothelial cell
number, even in the complete absence of blood flow. We therefore
sought to identify whether other forms of angiogenesis might be more
sensitive to alterations in blood flow.
Up-regulation of hypoxic signalling induces a profoundly
pro-angiogenic response, and unsurprisingly constitutive activation of
this process by homozygousmutationof vhl induces excessive angiogen-
esis in the ISVs of developing zebrafish embryos. We show for the first
time that angiogenesis promoted by this up-regulation of hypoxic signal-
ling is prevented in the absence of blood flow. Although a recent study
has suggested that a reduction in cardiac outputmay induce hypoxic sig-
nalling in zebrafish, this occurred after 7 dpf,31 significantly later than the
3–5 dpf embryos examined in our work. Even if reducing blood flow
Figure 6 Pharmacological inhibition of blood flow blocks excessive angiogenesis in vhl2/2 mutant zebrafish. (A) 3 dpf Tg(kdrl:memRFP; flk1:EGFP-nls)
double transgenic wild type or vhl2/2 mutants, treated with vehicle or [15 mM] BDM to stop blood flow from 36 hpf until 3 dpf (site of imaging boxed
in A). (B) A total vessel length at 3 dpf of wt, vhl2/2, and BDM-treated groups. (C) The mean number of endothelial nuclei in a two-somite mid-trunk
region in wt and vhl2/2 treated with BDM or vehicle.
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induced hypoxia, this would be predicted to increase, not decrease the
angiogenic response.
Weareunable to say forcertainhowcessationofbloodflowexerts its
effect on Notch signalling and aberrant angiogenesis in vhl mutants.
Various stimuli will occur in response to either preventing or halting
blood flow in the vasculature, as we achieved in ourmodels. Even if oxy-
genation is maintained, it is possible that CO2, being a larger, less diffus-
ible molecule may have accumulated in the tissue. Since teleosts have
been shown to possess carbonic anhydrase,32 an accumulation of CO2
could lead to increased osmotically active HCO3
2 which themselves
may induce alterations in physical forces exerted on the vasculature.
However, we believe that the effects of blood flow on Notch signalling
and angiogenesis seen in our study are more likely to be exerted via
mechanotransduction of the physical forces exerted by blood flow,
rather than biochemically.
vhl2/2 mutants experience increased levels of cardiac output and
blood flow,14 and this must be considered in interpreting our results.
It is possible that increased levels of blood flow might suppress Notch
signalling still further than in wild types, and this would be predicted to
lead to increased angiogenesis. However, as VEGF inhibition reduces
angiogenesis in vhl mutants, it seems likely the abnormal angiogenesis
seen in these mutants is predominantly driven by hypoxic signalling,
rather than by increased blood flow. Nevertheless, our data suggest
that blood flow and hypoxic signalling integrate at some level to
permit angiogenesis.
Our work has several limitations. Most notably, we have been unsuc-
cessful in demonstrating whether the requirement for blood flow in
hypoxic-signalling driven angiogenesis is mediated by suppression of
Notch signalling. Notch inhibition in vhl mutants without blood flow,
either by morpholino knockdown of dll4 or pharmacological inhibition
with gamma secretase inhibitors leads to embryonic death, which has
prevented us from testing the hypothesis that Notch inhibition might
rescue the excessive angiogenesis in vhl mutants even in the absence
of blood flow. Exposing embryos directly to hypoxia reduces blood
flow. This prevented us from examining the interaction of blood flow
with angiogenesis stimulated by low oxygen tension (true hypoxia) as
opposed to angiogenesis driven by up-regulated hypoxic signalling in
normoxic conditions as in the vhlmutant. Nevertheless, the twin obser-
vations that blood flow suppressesNotch signalling via the repression of
dll4 expression, and that blood flow is required for angiogenesis driven
by hypoxic signalling, both add to our understanding of how blood flow
maycontribute to angiogenesis, andunderline thatmechanismsof angio-
genesis differ according to context.
Our data suggest that targeting mechanosensory pathways that
sense blood flow might prevent angiogenesis in situations where this
is driven by hypoxia. This could potentially open novel therapeutic
strategies for conditions such as diabetic retinopathy where ischaemia
stimulates the neoangiogenesis that leads to visual impairment.33 In
addition, sinceNotch inhibitionmay sensitize some tumours to chemo-
therapy,34 an ability to down-regulate Notch by exposure to fluid
forces or blood flowmight have adjuvant benefits for cancer therapeu-
tics. As VEGF drives much of the angiogenic reponse to hypoxia, a re-
quirement for blood flow for angiogenesis to occur in response to
VEGF could underlie the disappointing clinical results of VEGF treat-
ment for coronary artery disease35 as it may not have induced neovas-
cularizationwhen delivered topoorly perfused tissues. Further studyof
the interactions between blood flow and angiogenesis seems likely to
reveal further intricacies of the regulation of vascular formation in de-
velopment and disease.
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